Study Stopped
Insufficient personel
Postpartum Readmission
Postpartum Preeclampsia Readmission
1 other identifier
observational
335
0 countries
N/A
Brief Summary
This is a retrospective chart review of women who labored and delivered in a single health care center. From that large group the investigators will evaluate women who were re-admitted in the post partum period for a hypertensive disorder. The study will also look at "Controls," a group of women with similar risk factors but did not require readmission.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2017
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2017
CompletedFirst Submitted
Initial submission to the registry
January 18, 2017
CompletedFirst Posted
Study publicly available on registry
January 20, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2017
CompletedOctober 11, 2017
October 1, 2017
8 months
January 18, 2017
October 10, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
hypertension
compare these two groups during the antepartum period, labor, delivery and post partum course for possible preceding signs (blood pressures) of those at risk for re admission for hypertensive disorders.
1 year
Study Arms (2)
readmit
women who were re-admitted in the post partum period for a hypertensive disorder
Controls
women with similar risk factors but did not require readmission
Eligibility Criteria
Women postpartum who are re-admitted for hypertension disorders
You may qualify if:
- Women who labored and delivered at a single hospital Readmitted (within 6 weeks post partum (PP) or less)to the hospital for hypertension disorder, with or without hypertension (HTN in pregnancy), gestational hypertension (gHTN), pre eclampsia (PreE), severe pre eclampsia (sPreE), HELLP ("HELLP" is an abbreviation of the three main features of the syndrome: Hemolysis. Elevated Liver enzymes. Low Platelet count.).
- Controls Group with PreE, not readmitted or No PreE
You may not qualify if:
- Hospital readmission for other complications.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Officials
- PRINCIPAL INVESTIGATOR
Jennifer Goldkamp, MD
St. Louis University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
January 18, 2017
First Posted
January 20, 2017
Study Start
January 1, 2017
Primary Completion
September 1, 2017
Study Completion
September 1, 2017
Last Updated
October 11, 2017
Record last verified: 2017-10
Data Sharing
- IPD Sharing
- Will not share